36氪获悉，香港初创企业生物医学科技控股有限公司（BioMed）完成种子轮融资，融资金额达200万美元。此轮投资方包括阿里巴巴香港创业者基金 （AEF）、戈壁大湾区 （Gobi Partners GBA）及全球药业有限公司（TIMC）。

Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over ...

Mainz Biomed N.V., a molecular genetics diagnostic company focused on early cancer detection, reported significant milestones for the first half of 2025, including the launch of the eAArly DETECT 2 US ...